Individual genomes instead of race for personalized medicine

Clinical Pharmacology and Therapeutics
P C NgJ C Venter

Abstract

The cost of sequencing and genotyping is aggressively decreasing, enabling pervasive personalized genomic screening for drug reactions. Drug-metabolizing genes have been characterized sufficiently to enable practitioners to go beyond simplistic ethnic characterization and into the precisely targeted world of personal genomics. We examine six drug-metabolizing genes in J. Craig Venter and James Watson, two Caucasian men whose genomes were recently sequenced. Their genetic differences underscore the importance of personalized genomics over a race-based approach to medicine. To attain truly personalized medicine, the scientific community must aim to elucidate the genetic and environmental factors that contribute to drug reactions and not be satisfied with a simple race-based approach.

References

Apr 29, 1998·JAMA : the Journal of the American Medical Association·J LazarouP N Corey
Mar 27, 2001·Annual Review of Pharmacology and Toxicology·H G XieC M Stein
Feb 27, 2007·Lancet·Troy Duster
Aug 11, 2007·Administration and Policy in Mental Health·Winnie W S MakEliseo J Pérez-Stable
Sep 7, 2007·PLoS Biology·Samuel LevyJ Craig Venter
Nov 23, 2007·Nucleic Acids Research·Tina Hernandez-BoussardTeri E Klein
Dec 19, 2007·Nature Reviews. Genetics·Amy L McGuireMildred K Cho
Dec 22, 2007·Science·Jocelyn Kaiser
Jan 16, 2008·The Pharmacogenomics Journal·B SéguinA S Daar
Apr 19, 2008·Nature·David A WheelerJonathan M Rothberg

❮ Previous
Next ❯

Citations

Jul 23, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Peter H O'Donnell, M Eileen Dolan
May 26, 2009·BMC Medical Genomics·Edward Ramos, Charles Rotimi
Mar 20, 2010·Critical Care : the Official Journal of the Critical Care Forum·Mirjam Christ-Crain, Steven M Opal
Apr 2, 2013·Personalized Medicine·Edward RamosCharles N Rotimi
May 11, 2011·Expert Review of Anticancer Therapy·Virginia G KaklamaniHenry L Gomez
Nov 10, 2009·Expert Review of Molecular Diagnostics·Anil S Modak
Apr 1, 2009·Expert Opinion on Drug Metabolism & Toxicology·Viet Hong PhanStephen J Clarke
Nov 10, 2015·Expert Opinion on Drug Metabolism & Toxicology·Nicholas Li-Xun SynBoon-Cher Goh
Feb 26, 2016·Science·Michael YudellSarah Tishkoff
Nov 14, 2008·Clinical Pharmacology and Therapeutics·D Gurwitz, J E Lunshof
Oct 27, 2010·PloS One·Lynn F CherkasBarbara Prainsack
Mar 18, 2011·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·S D J Pena
Jan 11, 2018·Therapeutic Advances in Drug Safety·Rashmi R Shah, Andrea Gaedigk
Jan 2, 2009·Clinical Pharmacology and Therapeutics·A AvihingsanonK Ruxrungtham
Apr 17, 2009·Clinical Pharmacology and Therapeutics·D A FlockhartA T Nguyen
Aug 1, 2019·Journal of the American Medical Informatics Association : JAMIA·Fernanda C G PolubriaginofDavid K Vawdrey
Feb 3, 2021·European Journal of Public Health·Michael Yudell
Oct 15, 2020·BMC Biology·Shashwat Deepali NagarI King Jordan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.